Trial Profile
Conversion of Twice-a-day Tacrolimus to Once-Daily Tacrolimus Extended-Release Formulation in Stable Pediatric Kidney Transplant Recipients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 29 May 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 26 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 25 Nov 2011 New trial record